ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: CML is mainly characterized by t (9; 22) (q34; q11) chromosomal translocation [2], giving rise to BCR-ABL1 p210 fusion protein with constitutive activation of tyrosine kinase activity.